Paper2385332
Behavioural and pharmacokinetic studies on nicotine, cytisine and lobeline.
Reavill C and 3 others. Neuropharmacology, 1990. Cited by 117 papers, by iCite.
Cite this record
ConductScience Library. Behavioural and pharmacokinetic studies on nicotine, cytisine and lobeline. Papers, record 2385332. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2385332
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alkaloids | Major topic |
| Behavior, Animal | Major topic |
| Lobeline | Major topic |
| Nicotine | Major topic |
| Animals | |
| Azocines | |
| Brain Chemistry | |
| Chromatography, High Pressure Liquid | |
| Male | |
| Quinolizines | |
| Rats | |
| Quinolizidine Alkaloids |
Source PubMed
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 117 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37519910 | New medications development for smoking cessation. | Addict Neurosci | 2023 | https://conductscience.org/library/papers/37519910 | PubMed |
| 35017179 | Neurobiological Mechanisms of Nicotine Reward and Aversion. | Pharmacol Rev | 2022 | https://conductscience.org/library/papers/35017179 | PubMed |
| 34744656 | Cotinine: Pharmacologically Active Metabolite of Nicotine and Neural Mechanisms for Its Actions. | Front Behav Neurosci | 2021 | https://conductscience.org/library/papers/34744656 | PubMed |
| 34205249 | Natural Alkaloid Compounds as Inhibitors for Alpha-Synuclein Seeded Fibril Formation and Toxicity. | Molecules | 2021 | https://conductscience.org/library/papers/34205249 | PubMed |
| 31315205 | Comparison of Various Chromatographic Systems for Analysis of Cytisine in Human Serum, Saliva and Pharmaceutical Formulation by HPLC with Diode Array, Fluorescence or Mass Spectrometry Detection. | Molecules | 2019 | https://conductscience.org/library/papers/31315205 | PubMed |
| 29587555 | Discovery and development of varenicline for smoking cessation. | Expert Opin Drug Discov | 2018 | https://conductscience.org/library/papers/29587555 | PubMed |
| 29191394 | Medications for alcohol use disorders: An overview. | Pharmacol Ther | 2018 | https://conductscience.org/library/papers/29191394 | PubMed |
| 29128873 | Reinforcement enhancement by nicotine in adult rats: behavioral selectivity and relation to mode of delivery and blood nicotine levels. | Psychopharmacology (Berl) | 2018 | https://conductscience.org/library/papers/29128873 | PubMed |
| 27421270 | New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline? | CNS Drugs | 2016 | https://conductscience.org/library/papers/27421270 | PubMed |
| 24901260 | Recent developments in novel antidepressants targeting α4β2-nicotinic acetylcholine receptors. | J Med Chem | 2014 | https://conductscience.org/library/papers/24901260 | PubMed |
| 24389640 | Methamphetamine-like discriminative-stimulus effects of nicotinic agonists. | J Pharmacol Exp Ther | 2014 | https://conductscience.org/library/papers/24389640 | PubMed |
| 23876236 | The effects of noncontingent and self-administered cytisine on body weight and meal patterns in male Sprague-Dawley rats. | Pharmacol Biochem Behav | 2013 | https://conductscience.org/library/papers/23876236 | PubMed |
| 23494230 | Multiple nicotine training doses in mice as a basis for differentiating the effects of smoking cessation aids. | Psychopharmacology (Berl) | 2013 | https://conductscience.org/library/papers/23494230 | PubMed |
| 23333294 | Patterns of nicotinic receptor antagonism II: cardiovascular effects in rats. | Drug Alcohol Depend | 2013 | https://conductscience.org/library/papers/23333294 | PubMed |
| 23024249 | Development of novel pharmacotherapeutics for tobacco dependence: progress and future directions. | Nicotine Tob Res | 2012 | https://conductscience.org/library/papers/23024249 | PubMed |
| 22244928 | The nicotine metabolite, cotinine, attenuates glutamate (NMDA) antagonist-related effects on the performance of the five choice serial reaction time task (5C-SRTT) in rats. | Biochem Pharmacol | 2012 | https://conductscience.org/library/papers/22244928 | PubMed |
| 21278851 | Preclinical Pharmacology, Efficacy and Safety of Varenicline in Smoking Cessation and Clinical Utility in High Risk Patients. | Drug Healthc Patient Saf | 2010 | https://conductscience.org/library/papers/21278851 | PubMed |
| 21217867 | Effect of cytisine on some brain and hepatic biochemical parameters in spontaneously hypertensive rats. | Interdiscip Toxicol | 2010 | https://conductscience.org/library/papers/21217867 | PubMed |
| 21049087 | Varenicline for smoking cessation: efficacy, safety, and treatment recommendations. | Patient Prefer Adherence | 2010 | https://conductscience.org/library/papers/21049087 | PubMed |
| 20331614 | Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence. | Br J Pharmacol | 2010 | https://conductscience.org/library/papers/20331614 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2385332
GET https://conductscience.org/api/papers/v1/2385332/cited_by?page=2